Stock Track | Mind Medicine (MindMed) Soars 6.87% After Oppenheimer's Bullish $25 Price Target

Stock Track

Aug 05, 2025

Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) are soaring 6.87% in intraday trading on Monday, following a bullish analyst rating from Oppenheimer. The surge comes as investors react positively to the new coverage, which signals strong confidence in the company's potential in the psychedelic therapeutics market.

Oppenheimer initiated coverage on Mind Medicine with an Outperform rating and set an ambitious price target of $25. This target represents a substantial upside from the stock's current trading levels, igniting investor enthusiasm. The bullish stance aligns with the overall sentiment among analysts polled by FactSet, who have given the company an average rating of "buy" with a mean price target of $25.

As Mind Medicine continues to advance its research and development in psychedelic-inspired medicines, this positive analyst coverage could potentially attract more investor attention to the company's growth prospects. The significant price target reflects optimism about Mind Medicine's position in the emerging field of psychedelic therapeutics, which has been gaining traction in recent years for its potential in treating various mental health conditions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1107823182"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1107823182\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1107823182?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 00:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107823182","market":"us","top_or_hot":-1,"title":"Stock Track | Mind Medicine (MindMed) Soars 6.87% After Oppenheimer's Bullish $25 Price Target","media":"Stock Track","content":"<p>Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) are soaring 6.87% in intraday trading on Monday, following a bullish analyst rating from Oppenheimer. The surge comes as investors react positively to the new coverage, which signals strong confidence in the company's potential in the psychedelic therapeutics market.</p>\n\n<p>Oppenheimer initiated coverage on Mind Medicine with an Outperform rating and set an ambitious price target of $25. This target represents a substantial upside from the stock's current trading levels, igniting investor enthusiasm. The bullish stance aligns with the overall sentiment among analysts polled by FactSet, who have given the company an average rating of \"buy\" with a mean price target of $25.</p>\n\n<p>As Mind Medicine continues to advance its research and development in psychedelic-inspired medicines, this positive analyst coverage could potentially attract more investor attention to the company's growth prospects. The significant price target reflects optimism about Mind Medicine's position in the emerging field of psychedelic therapeutics, which has been gaining traction in recent years for its potential in treating various mental health conditions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Mind Medicine (MindMed) Soars 6.87% After Oppenheimer's Bullish $25 Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Mind Medicine (MindMed) Soars 6.87% After Oppenheimer's Bullish $25 Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-05 00:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) are soaring 6.87% in intraday trading on Monday, following a bullish analyst rating from Oppenheimer. The surge comes as investors react positively to the new coverage, which signals strong confidence in the company's potential in the psychedelic therapeutics market.</p>\n\n<p>Oppenheimer initiated coverage on Mind Medicine with an Outperform rating and set an ambitious price target of $25. This target represents a substantial upside from the stock's current trading levels, igniting investor enthusiasm. The bullish stance aligns with the overall sentiment among analysts polled by FactSet, who have given the company an average rating of \"buy\" with a mean price target of $25.</p>\n\n<p>As Mind Medicine continues to advance its research and development in psychedelic-inspired medicines, this positive analyst coverage could potentially attract more investor attention to the company's growth prospects. The significant price target reflects optimism about Mind Medicine's position in the emerging field of psychedelic therapeutics, which has been gaining traction in recent years for its potential in treating various mental health conditions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1107823182","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107823182","pubTimestamp":1754325407,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) are soaring 6.87% in intraday trading on Monday, following a bullish analyst rating from Oppenheimer. The surge comes as investors react...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"股票追踪|奥本海默看涨25美元目标价后，Mind Medicine(MindMed)飙升6.87%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNMD":1},"content_text":"Shares of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) are soaring 6.87% in intraday trading on Monday, following a bullish analyst rating from Oppenheimer. The surge comes as investors react positively to the new coverage, which signals strong confidence in the company's potential in the psychedelic therapeutics market.\nOppenheimer initiated coverage on Mind Medicine with an Outperform rating and set an ambitious price target of $25. This target represents a substantial upside from the stock's current trading levels, igniting investor enthusiasm. The bullish stance aligns with the overall sentiment among analysts polled by FactSet, who have given the company an average rating of \"buy\" with a mean price target of $25.\nAs Mind Medicine continues to advance its research and development in psychedelic-inspired medicines, this positive analyst coverage could potentially attract more investor attention to the company's growth prospects. The significant price target reflects optimism about Mind Medicine's position in the emerging field of psychedelic therapeutics, which has been gaining traction in recent years for its potential in treating various mental health conditions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}